Harshan KH - Search Results

1

SARS-CoV-2 Binding to Terminal Sialic Acid of Gangliosides Embedded in Lipid Membranes.

Negi G, Sharma A, Chaudhary M, Gupta D, Harshan KH, Parveen N. Negi G, et al. Among authors: harshan kh. ACS Infect Dis. 2023 Jul 14;9(7):1346-1361. doi: 10.1021/acsinfecdis.3c00106. Epub 2023 May 5. ACS Infect Dis. 2023. PMID: 37145972

2

mTORC1 restricts hepatitis C virus RNA replication through ULK1-mediated suppression of miR-122 and facilitates post-replication events.

Johri MK, Lashkari HV, Gupta D, Vedagiri D, Harshan KH. Johri MK, et al. Among authors: harshan kh. J Gen Virol. 2020 Jan;101(1):86-95. doi: 10.1099/jgv.0.001356. J Gen Virol. 2020. PMID: 31821132

3

Retinoic Acid-Inducible Gene I-Like Receptors Activate Snail To Limit RNA Viral Infections.

Vedagiri D, Gupta D, Mishra A, Krishna G, Bhaskar M, Sah V, Basu A, Nayak D, Kalia M, Valiya Veettil M, Harshan KH. Vedagiri D, et al. Among authors: harshan kh. J Virol. 2021 Oct 13;95(21):e0121621. doi: 10.1128/JVI.01216-21. Epub 2021 Aug 11. J Virol. 2021. PMID: 34379517 Free PMC article.

4

Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential.

Gupta D, Parthasarathy H, Sah V, Tandel D, Vedagiri D, Reddy S, Harshan KH. Gupta D, et al. Among authors: harshan kh. Virus Res. 2021 Nov;305:198555. doi: 10.1016/j.virusres.2021.198555. Epub 2021 Sep 4. Virus Res. 2021. PMID: 34487766 Free PMC article.

5

Correction for Vedagiri et al., "Retinoic Acid-Inducible Gene I-Like Receptors Activate Snail To Limit RNA Viral Infections".

Vedagiri D, Gupta D, Mishra A, Krishna G, Bhaskar M, Sah V, Basu A, Nayak D, Kalia M, Valiya Veettil M, Harshan KH. Vedagiri D, et al. Among authors: harshan kh. J Virol. 2022 Jan 26;96(2):e0182221. doi: 10.1128/JVI.01822-21. Epub 2022 Jan 26. J Virol. 2022. PMID: 35080452 Free PMC article. No abstract available.

6

Equine immunoglobulin fragment F(ab')₂ displays high neutralizing capability against multiple SARS-CoV-2 variants.

Gupta D, Ahmed F, Tandel D, Parthasarathy H, Vedagiri D, Sah V, Krishna Mohan B, Khan RA, Kondiparthi C, Savari P, Jain S, Reddy S, Kumar JM, Khan N, Harshan KH. Gupta D, et al. Among authors: harshan kh. Clin Immunol. 2022 Apr;237:108981. doi: 10.1016/j.clim.2022.108981. Epub 2022 Mar 17. Clin Immunol. 2022. PMID: 35306171 Free PMC article.

7

SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells.

Tandel D, Sah V, Singh NK, Potharaju PS, Gupta D, Shrivastava S, Sowpati DT, Harshan KH. Tandel D, et al. Among authors: harshan kh. Microbiol Spectr. 2022 Oct 26;10(5):e0160422. doi: 10.1128/spectrum.01604-22. Epub 2022 Sep 8. Microbiol Spectr. 2022. PMID: 36073824 Free PMC article.

8

A comparative study of antibody response, virus neutralization efficiency & metabolites in SARS-CoV-2-infected adults & children.

Sudhakar R, Dontamala S, Bingi TC, Gorde S, Panda A, Rizvi Z, Reddy GS, Kaswan S, Bhattacharjee M, Kumar D, Nivya MA, Mesipogu RR, Varadarajan KS, Patel AB, Gupta D, Harshan KH, Tallapaka KB, Sijwali PS. Sudhakar R, et al. Among authors: harshan kh. Indian J Med Res. 2022 Oct-Nov;156(4&5):659-668. doi: 10.4103/ijmr.ijmr_3475_21. Indian J Med Res. 2022. PMID: 36926783 Free PMC article.

9

G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters.

Roy SS, Sharma S, Rizvi ZA, Sinha D, Gupta D, Rophina M, Sehgal P, Sadhu S, Tripathy MR, Samal S, Maiti S, Scaria V, Sivasubbu S, Awasthi A, Harshan KH, Jain S, Chowdhury S. Roy SS, et al. Among authors: harshan kh. Front Mol Biosci. 2023 Mar 16;10:1133123. doi: 10.3389/fmolb.2023.1133123. eCollection 2023. Front Mol Biosci. 2023. PMID: 37006620 Free PMC article.

10

Redirecting the JAK-STAT signal blocks the SARS-CoV-2 replication.

Augustine G, Sisila V, Indhu M, Gupta D, Tandel D, Harshan KH, Shanmugam G, Padmapriya P, Sivasubramanian S, Kaveri K, Ramudu KN, Ayyadurai N. Augustine G, et al. Among authors: harshan kh. J Med Virol. 2023 Jul;95(7):e28965. doi: 10.1002/jmv.28965. J Med Virol. 2023. PMID: 37488710

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page